Loading insider details...
Beta
Latest Form 4 (May 20, 2026): Grant/Award of 150,000 BCLI shares, $105.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 20, 2026 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 150,000 | $105.0K |
| Jan 3, 2025 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 24,000 | n/a |
| Feb 3, 2022 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 3,882 | n/a |
| Dec 17, 2021 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 2,000 | n/a |
| Dec 10, 2021 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 2,216 | n/a |
| Feb 14, 2020 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 2,000 | n/a |